Unknown

Dataset Information

0

Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex.


ABSTRACT: mAb B4 is a monoclonal antibody directed against HIV receptor complex. The antibody had broad neutralizing activity against HIV and provided postexposure prophylaxis to hu-peripheral blood leukocyte (PBL)-severe combined immunodeficient mice and chimpanzees. B4 recognized a complex receptor site for HIV on the T cell surface that includes CD4 and also may be influenced by interaction with HIV coreceptors. mAb B4 preferentially neutralized primary HIV-1 isolates compared with T cell line-adapted strains, including syncytium-inducing and non-syncytium-inducing phenotypes, representatives from HIV-1 subtypes A-G, as well as HIV-2, simian immunodeficiency virus, and chimeric simian/human immunodeficiency virus (SHIV). Neutralization was demonstrated in both pre- and postinfection models. The administration of mAb B4 after infectious challenge totally interrupted the infection of hu-PBL-severe combined immunodeficient mice by PBL-grown HIV-1 and the infection of chimpanzees by chimp-adapted HIV-1. This mode of protection suggested that the anti-HIV receptor antibody is efficacious for prophylaxis after exposure to HIV and for prevention of maternal transmission and may be an effective antiretroviral agent for treatment.

SUBMITTER: Wang CY 

PROVIDER: S-EPMC17894 | biostudies-other | 1999 Aug

REPOSITORIES: biostudies-other

altmetric image

Publications

Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex.

Wang C Y CY   Sawyer L S LS   Murthy K K KK   Fang X X   Walfield A M AM   Ye J J   Wang J J JJ   Chen P D PD   Li M L ML   Salas M T MT   Shen M M   Gauduin M C MC   Boyle R W RW   Koup R A RA   Montefiori D C DC   Mascola J R JR   Koff W C WC   Hanson C V CV  

Proceedings of the National Academy of Sciences of the United States of America 19990801 18


mAb B4 is a monoclonal antibody directed against HIV receptor complex. The antibody had broad neutralizing activity against HIV and provided postexposure prophylaxis to hu-peripheral blood leukocyte (PBL)-severe combined immunodeficient mice and chimpanzees. B4 recognized a complex receptor site for HIV on the T cell surface that includes CD4 and also may be influenced by interaction with HIV coreceptors. mAb B4 preferentially neutralized primary HIV-1 isolates compared with T cell line-adapted  ...[more]

Similar Datasets

| S-EPMC3005625 | biostudies-literature
| S-EPMC3323977 | biostudies-literature
| S-EPMC6789020 | biostudies-literature
| S-EPMC4542390 | biostudies-literature
| S-EPMC4547275 | biostudies-literature
| S-EPMC5117957 | biostudies-literature
| S-EPMC5028908 | biostudies-literature
| S-EPMC5629912 | biostudies-literature
| S-EPMC21372 | biostudies-literature
| S-EPMC4488766 | biostudies-other